Last updated: October 27, 2021
Sponsor: National Taiwan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Reflex Sympathetic Dystrophy Syndrome (Rsds)
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05112094
202105016RIPB
Ages 20-100 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
- >=20 years old
- Stroke in recent 6 months
- Clear consciousness
- Clinical diagnosis of post-stroke shoulder-hand syndrome
Exclusion
Exclusion criteria:
- Acute bursitis, tendonitis or tendon tear
- Fracture, dislocation or joint infection within 3 months
- Malignancy at treatment site
- Seizure
- Prosthesis or implant at treatment site
- Pregnancy
Study Design
Total Participants: 40
Study Start date:
August 01, 2021
Estimated Completion Date:
June 30, 2022
Study Description
Connect with a study center
National Taiwan University Hospital
Taipei, 100
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.